Vedan­ta opens man­u­fac­tur­ing fa­cil­i­ty to pro­duce lead can­di­date as it heads for PhI­II

The mi­cro­bio­me start­up Vedan­ta, while still forg­ing ahead with the Phase III process for its Clostrid­ioides dif­fi­cile in­fec­tion can­di­date, has com­plet­ed a man­u­fac­tur­ing fa­cil­i­ty to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER